利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

14 条记录 (耗时 0.015 秒)

    Composition for treatment of asthma
    1.
    发明授权
    Composition for treatment of asthma 有权
    用于治疗哮喘的组合物

    公开(公告)号：US07255884B2

    公开(公告)日：2007-08-14

    申请号：US10683984

    申请日：2003-10-02

    申请人： Hongfen Li

    发明人： Hongfen Li

    IPC分类号： A61K36/00 ,  A61K36/236 ,  A61K36/718 ,  A61K36/736

    CPC分类号： A61K36/8966 ,  A61K36/17 ,  A61K36/238 ,  A61K36/28 ,  A61K36/344 ,  A61K36/355 ,  A61K36/481 ,  A61K36/484 ,  A61K36/487 ,  A61K36/535 ,  A61K36/538 ,  A61K36/539 ,  A61K36/56 ,  A61K36/634 ,  A61K36/65 ,  A61K36/718 ,  A61K36/734 ,  A61K36/736 ,  A61K36/756 ,  A61K36/79 ,  A61K36/8998 ,  A61K36/904 ,  A61K2300/00

    摘要： A pharmaceutical preparation of Chinese herbal medicines for tonifying the kidneys and alleviating asthma is disclosed herein. The Chinese herbal medicines include Perilla Frutescens, Prunus Armeniaca, Glycyrrhiza Uralensis, Scutellaria Baicalensis, Coptis Chinesis, Tusilago Farfara, Stemona Sessilifolia, Fritillaria Cirrhosa, Pheretima Aspergillum, Psoralaea Corylifolia, Codonopsis Pilosula, Hordeum Vulgara, Massa Fermentata Medicalis, Schisandra Chinesis, and Gypsum. The preparation is used to treat thousands of patients suffering from asthma with an effective rate of 93%. The present preparation can relieve cough, expel phlegm, resist airway allergic inflammation reaction, improve pulmonary function, partial pressure of the oxygen in the blood, increase CD2, CD4, CD4/CD8, reduce IgE in blood, increase CAMP, reduce CGMP, stabilize mast cells, and inhibit the release of histamine, which make it capable of stopping an asthma attack.

    摘要翻译： 本文公开了用于调节肾脏和减轻哮喘的中草药药物制剂。 中草药包括紫苏，紫薇，黄连，黄连，，olia olia olia olia olia，um um um um um um um um um um um um um um um um um um um um um um um um um um um um um um um um um um um um um um 。 该制剂用于治疗数千例哮喘患者，有效率为93％。 本制剂可缓解咳嗽，排泄痰，抵抗气道过敏性炎症反应，改善肺功能，血液中氧气分压，增加CD <2>，CD 4， CD 3 / CD 8，降低血液中的Iκ，增加CAMP，减少CGMP，稳定肥大细胞，并抑制组胺的释放 ，使其能够停止哮喘发作。

    Composition for treatment of asthma
    5.
    发明申请
    Composition for treatment of asthma 有权
    用于治疗哮喘的组合物

    公开(公告)号：US20040071796A1

    公开(公告)日：2004-04-15

    申请号：US10683984

    申请日：2003-10-02

    发明人： Hongfen Li

    IPC分类号： A61K035/78

    CPC分类号： A61K36/8966 ,  A61K36/17 ,  A61K36/238 ,  A61K36/28 ,  A61K36/344 ,  A61K36/355 ,  A61K36/481 ,  A61K36/484 ,  A61K36/487 ,  A61K36/535 ,  A61K36/538 ,  A61K36/539 ,  A61K36/56 ,  A61K36/634 ,  A61K36/65 ,  A61K36/718 ,  A61K36/734 ,  A61K36/736 ,  A61K36/756 ,  A61K36/79 ,  A61K36/8998 ,  A61K36/904 ,  A61K2300/00

    摘要： The present invention discloses a pharmaceutical preparation of Chinese herbal medicines which consists of Chinese herbal medicines for tonifying kidney and antiasthma, wherein the Chinese herbal medicines are Perilla Frutescens, Prunus Armeniaca, Glycyrrhiza Uralensis, Scutellaria Baicalensis, Coptis Chinesis, Tusilago Farfara, Stemona Sessilifolia, Fritllaria Cirrhosa, Pheretima Aspergillum, Psoralea Corylifolia, Codonopsis Pilosula, Hordeum Vulgara, Massa Fermentata Medicalis, Schisandra Chinensis, Gypsum. The preparation has been used in China for 20 years, and in Israel for more than 5 years. It has been used to treat thousands of patients suffering from asthma with an effective rate of 93%. The present preparation can relieve cough, expel phlegm, resist airway allergic inflammation reaction, improve pulmonary function, partial pressure of the oxygen in blood and increase CD2, CD4, CD4/CD8, reduce IgE in blood, and increase CAMP, reduce CGMP, stabilize mast cells, inhibit the release of histamine, which makes it capable of stopping the attack of asthma. As shown with an electron microscope, the preparation protects lung cells, increases lung cells of type 2, and recovers the lung's capacity. It can be applied to the hormone dependent patients for decreasing and ceasing the administration of hormone by adjusting hypothalamic-pituitary-adrenal axis. To further demonstrate the therapeutic effect, a clinical trial carried in the Tel-Hashomer Hospital of Israel proved the preparation can improve asthma significantly.

    摘要翻译： 本发明公开了一种中草药药物制剂，由中草药调理肾脏和抗哮喘药，其中中草药为紫苏，紫花苜蓿，甘草，黄连，黄连，中国草药， Fritllaria Cirrhosa，Pheretima Aspergillum，Psoralea Corylifolia，Codonopsis Pilosula，Hordeum Vulgara，Massa Fermentata Medicalis，五味子中药，石膏。 这项准备工作在中国已经使用了20年，在以色列已有五年多了。 已被用于治疗数千名哮喘患者，有效率为93％。 本制剂可缓解咳嗽，排痰，抵抗气道过敏性炎症反应，改善肺功能，血液中氧气分压，增加CD2，CD4，CD4 / CD8，降低血液中的IgE，增加CAMP，降低CGMP，稳定 肥大细胞，抑制组胺的释放，使其能够阻止哮喘的发作。 如电子显微镜所示，该制剂保护肺细胞，增加2型肺细胞，并恢复肺的能力。 通过调整下丘脑 - 垂体 - 肾上腺轴，可以将其应用于依赖激素的患者减少和停止激素的给药。 为了进一步证明治疗效果，以色列Tel-Hashomer医院进行的临床试验证明，该制剂可以显着改善哮喘。